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http://dx.doi.org/10.1016/j.ccr.2013.08.023SUMMARYDissemination of cancer cells from primary tumors is the key event in metastasis, but specific determinants
are widely unknown. Here, we show that DNp73, an inhibitor of the p53 tumor suppressor family, drives
migration and invasion of nonmetastatic melanoma cells. Knockdown of endogenous DNp73 reduces this
behavior in highly metastatic cell lines. Tumor xenografts expressing DNp73 show a higher ability to invade
and metastasize, while growth remains unaffected. DNp73 facilitates an EMT-like phenotype with loss of
E-cadherin and Slug upregulation. We provide mechanistic insight toward regulation of LIMA1/EPLIN by
p73/DNp73 and demonstrate a direct link between the DNp73-EPLIN axis and IGF1R-AKT/STAT3 activation.
These findings establish initiation of the invasion-metastasis cascade via EPLIN-dependent IGF1R regulation
as major activity of DNp73.INTRODUCTION
Metastasis is the main cause of death in patients with cancer. A
very early event in which cancer cells switch to an invasive and
aggressive phenotype is known as epithelial-mesenchymal
transition (EMT). A widely accepted marker for EMT is loss of
E-cadherin and the upregulation of its repressing genes in-
cluding TWIST1, TWIST2, ZEB1, SNAI1 (Snail), or SNAI2 (Slug).
Beyond that point, tumor cells gain invasiveness, lose cell-cell
contacts, and infiltrate the surrounding tissue. Extensive studies
have been undertaken to clarify this multistep process whereasSignificance
DNp73 was described as a driving force in transformation by s
tually tumor formation. Its frequent upregulation in high-grade t
this oncogene beyond tumorigenesis. Here, we show that DN
changes, migration, and invasiveness. We have identified a k
aggressive that reflects its ability to interfere with p73 func
STAT3 activation and loss of E-cadherin. The evidence for an ax
ative mechanism of DNp73-induced neoplastic dissemination c
cess of metastasis initiation and expands the possibilities for
512 Cancer Cell 24, 512–527, October 14, 2013 ª2013 Elsevier Inc.major players, especially those that regulate EMT and thus, acti-
vate cancer cell spreading, remain to be identified. Designing
therapies that interrupt metastasis at an early state might be a
promising approach to improve patient survival.
p73 is a member of the p53 tumor suppressor family and acts
as a negative regulator of cancer development by inducing cell
cycle arrest and apoptosis through its ability to bind p53 DNA
target sites. In contrast to p53, p73 is essentially never mutated
in cancer. The TP73 gene produces transactivation-deficient
N-terminally truncated isoforms (DNp73, DN0p73, DEx2p73,
and DEx2/3p73), named DNp73. These isoforms can inhibittimulating apoptosis resistance, aberrant growth, and even-
umors, however, raises the question about the further role of
p73 promotes melanoma metastasis by triggering EMT-like
ey mechanism by which DNp73 renders cancer cells highly
tion on LIMA1/EPLIN expression, resulting in IGF1R-AKT/
is consisting of DNp73-EPLIN-IGF1R-AKT/STAT3 as a caus-
ontributes to uncover the yet incompletely understood pro-
early therapeutic intervention.
Figure 1. DNp73 Enhances Motility and Invasion of Malignant Melanoma Cells
(A) Detection of the invasive potential (bars) of indicated melanoma cell lines in correlation with endogenous p73 and DNp73 protein levels. Fold changes were
calculated relative to SK-Mel-28 (set as 1). Data are represented as mean ± SD of three independent experiments. Actin served as loading control.
(B) Invasion of SK-Mel-29.DNp73 (top left) andMel888 cells infectedwith Ad.DNp73 (bottom left). Representative images of wound closure assays at 48 and 72 hr
after scratching (right). Quantitative data of three independent experiments at 72 hr are shown. Fold changes are relative to the controls. Values are means ± SD.
*p < 0.05. See also Figure S1.
(legend continued on next page)
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Initiation of Invasion-Metastasis Cascade by DNp73p53 and p73 by either directly blocking the promoter of target
genes or by forming inactive heteromeric complexes with wild-
type p73 (Stiewe et al., 2002a; Slade et al., 2004). Inhibitory
p73 was found to be overexpressed in various types of human
cancer, but not in healthy tissues (Buhlmann and Pu¨tzer, 2008).
By counteracting the growth-suppressive properties of p53
and p73, DNp73 serves as survival factor that confers drug resis-
tance to tumor cells harboring wild-type p53/p73 (Buhlmann and
Pu¨tzer, 2008). Studies in mice confirmed that DNp73 transforms
NIH/3T3 fibroblasts and normal hepatocytes to tumorigenicity
and cooperates with oncogenic Ras in transforming primary
mouse embryonic fibroblasts (Stiewe et al., 2002b; Petrenko
et al., 2003; Tannapfel et al., 2008). Intriguingly, analyses in
patients with skin cancer with wild-type p53 and p73 showed
higher expression of antagonistic p73 isoforms in metastases
than in primary melanomas (Tuve et al., 2004). This finding raises
the question whether DNp73 has additional activities that lead to
cancer progression and prompted us to investigate its role in
regulating malignant phenotypes of melanoma.
RESULTS
NH2-Truncated p73 Drives Migration and Invasion in
Human Melanoma Cells
To study DNp73’s role in tumor progression, we utilized a human
melanoma tissue culture model consisting of ten distinct cell
lines that differ in their invasive/metastatic potential. While SK-
Mel-103, SK-Mel-147, A375M, WM793, and C8161 are highly
invasive (Figure 1A) and metastatic in mouse xenograft models,
SK-Mel-19, SK-Mel-28, SK-Mel-29, SK-Mel-94, and Mel888 are
not (Ferna´ndez et al., 2005; Wolter et al., 2007; Alla et al., 2010;
Sousa and Espreafico, 2008; Jean et al., 1998; Gallagher et al.,
2005). Thus, our system mimics the findings in patient tumor
samples as seen by a higher expression of DNp73 in metastatic
versus nonmetastatic tumor cells (Figure 1A). We established
clonal SK-Mel-29 cell lines that stably express the DEx2/3p73
isoform, which is specifically elevated in progressed melanomas
(Tuve et al., 2004), and analyzed their capacity to invade matri-
gel. DNp73 considerably enhanced the number of invading cells
compared to control SK-Mel-29 (Figure 1B, top left). The same
effect was observed after infection of Mel888 (Figure 1B, bottom
left) and SK-Mel-29 (Figure S1A available online) with Ad.DNp73,
which indicates that the motility is enhanced by DNp73 overex-
pression. Increased migration was also evident from wound
healing assays where significantly more SK-Mel-29.DNp73 cells
migrated across the scratched area than the control, leading to
an almost complete gap closure within 72 hr (Figure 1B, right).
To examine, whether endogenously high DNp73 contributes to
invasiveness, we blocked DNp73 in four invasively growing cell(C) Boyden chamber assay of different highly metastatic melanoma cell lines afte
ASO (ASOscr). Values are means ± SD. *p < 0.05.
(D) Morphology of SK-Mel-29 and SK-Mel-29.DNp73 infected with Ad.shp73 or
indicate DNp73 and MITF expression in the cells. Scale bar, 25 mm.
(E) Stable DNp73-expressing SK-Mel-29 (b, d) or ASO116 treated A375M and
diumiodid, PI/red and DAPI/blue) were visualized by confocal fluorescence micros
fibers aligned along the major cell axis (Scale bar, 10 mm). Percentages of cells w
33 ± 12; p < 0.05) and WM793 (g, ASOscr 75 ± 23; h, ASO116 14 ± 22; p < 0.01
(F) Adhesion of SK-Mel-29.DNp73 relative to SK-Mel-29 (set as 1) on laminin and
duplicates. *p < 0.01.
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DEx2/3p73 isoform but not wild-type p73 as described previ-
ously (Emmrich et al., 2009). Compared to cells treated with
nonspecific ASO, efficient knockdown of endogenous DNp73
significantly impaired their invasiveness (Figure 1C). Importantly,
in contrast to nontransformed cells, truncated p73 in melanoma
cells does not induce cell proliferation (Figure S1B).
DNp73-driven invasion of initially less aggressive melanoma
cells is also attended by altered cell morphology. The appear-
ance of SK-Mel-29 cells with long branched dendrites was
replaced by a spindle-shaped invasive phenotype without den-
dritic processes under DNp73 expression (Figure 1D). Invasive
SK-Mel-29.DNp73 cells reverted to the dendritic state after
anti-p73 shRNA knockdown. Increased expression of DNp73
in SK-Mel-29 is associated with loss of microphthalmia-associ-
ated transcription factor (MITF) protein that serves as a marker
for proliferative melanoma cells and is absent from the invasive
state (Hoek et al., 2008), whereas MITF expression increases
after gene silencing. Consistent with the changes in morphology
and motility, DNp73 expression results in the reorganization of
the cytoskeleton as evident from the emergence of longitudi-
nally organized actin fibers in SK-Mel-29.DNp73 cells (Figure 1E,
subpanels b and d) and pronounced adhesion on laminin and
fibronectin (Figure 1F). Conversely, actin remodelling mani-
fested as the rearrangement of stress fibers and the loss of
well-organized actin filament bundles oriented parallel to the
major cell axis is induced upon specific depletion of DNp73 in
metastatic skin cancer cell lines compared to the controls (Fig-
ure 1E, bottom). This effect is associated with morphological
changes such as alterations in cell polarization that resemble
less invasive cells and could contribute to their reduced migra-
tory capability.
DNp73 Is Essential for Tumor Invasion and Metastasis
in Mice
We then assessed the oncogenic potential of DNp73-expressing
melanoma cells as subcutaneous xenografts and after trans-
plantation into the mammary fat pads of nude mice. Irrespective
of carrying DNp73 or not, subcutaneously (s.c.) established
tumors showed basically the same growth rates (Figure 2A).
While overexpression of DNp73 had no measurable effect on
regional growing melanoma, tumors originating from DNp73-
expressing cells were significantly more invasive than those
formed by controls (Figures 2B and 2C). Moreover, all mice
that received fat pad injections of DNp73 melanoma cells devel-
oped micrometastases in lungs and liver, which were not seen in
animals injected with cells not carrying DNp73 (Figure 2D).
DNp73 expression in the invasive tumors was confirmed with
qRT-PCR and western blot (Figure 2B, right).r ASO116 treatment. Fold changes are relative to cells treated with scrambled
control Ad.shGFP determined by phase contrast microscopy. Immunoblots
WM793 (bottom) stained for F-actin (phallacidin, green/red) and DNA (propi-
copy compared to SK-Mel-29 (a, c) or ASOscr controls. Arrows indicate stress
ith stress fiber alignment are as follows: A375M (e, ASOscr 63 ± 14; f, ASO116
).
fibronectin. Bars represent mean ± SD of three separate samples measured in
Figure 2. DNp73 Expression Drives Tumor
Invasion and Metastasis In Vivo
(A) Growth of mock and SK-Mel-29.DNp73-
derived s.c. tumors. Data representmean volumes
from each group (n = 5) ± SD at indicated time
points.
(B) Representative micrographs of H&E stained
tumor sections. SK-Mel-29 cells without DNp73
generate solid s.c. tumors. Asterisk indicates
epidermis (a). Tumor mass with necrotic area
(open arrow) and small capsule (asterisk) (b) is
shown. SK-Mel-29.DNp73 cells show solid tumor
masses and single cell invasion (c). Single cell
invasion into surrounding connective tissue
(d, open arrows) is shown. DNp73 tumors also
exhibit invasion seen as tumor fingers (e, open
arrows). Lateral tumor mass invasion (f). Scale
bars: a, 500 mm; b and f, 100 mm; c and e, 1 mm;
d, 200 mm. Individual tumor volumes at the time of
tissue removal were 964.64 mm3 (a), 1095.38 mm3
(c), and 935.19 mm3 (e). Detection of DNp73
expression in invasive tumors (n = 3; *p % .05)
originated from SK-Mel-29.DNp73 cells by
qRT-PCR and western blot (right). Fold expression
was calculated relative to the level of primary
SK-Mel-29 tumors set as 1. Actin was used as
loading control. Statistical significance was
determined by Student’s t test (two tailed). Values
are means ± SD.
(C) Invasive capacity of s.c. xenograft tumors with
and without DNp73 expression.
(D) Representative lungs and liver H&E sections
from mice carrying mammary tumors of mock
and stably DNp73 expressing SK-Mel-29 cells.
a, tumor, scale bar, 250 mm, fatty tissue infiltration;
b, tumor, scale bar, 100 mm, melanocytic differ-
entiation, necrotic area, foliate growth pattern;
c, perivascular liver metastasis overview, scale
bar, 250 mm; d, perivascular liver metastasis, scale
bar, 100 mm, asterisk, liver vein, arrow, bile duct;
e, perivascular lung metastasis overview, scale
bar, 1,000 mm; f, perivascular lung metastasis,
scale bar, 100 mm, asterisk, macrophage reaction;
arrow, perivascular tumor cells and lymphocyte
reaction.
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Progression in DNp73 Melanoma Cells
Considering that DNp73 is expressed at higher levels in metasta-
tic melanoma (Figure 1A), we performed gene expression
profiling in nonmetastatic and stable DNp73-expressing SK-
Mel-29 compared to SK-Mel-103 and SK-Mel-147 cells. Hierar-
chical clustering revealed significantly altered expression of
1,376 genes between SK-Mel-29 with and without DNp73 (Fig-
ure 3A, left); 1,041 genes regulated by DNp73 were also differen-Cancer Cell 24, 512–527,tially expressed in metastatic versus
nonmetastatic tumor cells. As indicated
in Figure 3A (right), most genes that
showed expressional changes associ-
atedwith highDNp73 affect cell migration
and enzyme-linked receptor signaling,
cell membrane/ECM components, and
cytoskeletal protein binding. Functionalannotation displayed several genes that are related to progres-
sion from melanoma to invasive and metastasizing lesions
(S100A2, S100A4, and DPP4), and cell death-associated genes
(Figure 3B). This includes antiapoptotic CCL2 and genes with
proapoptotic function (ATM, HRK, and MOAP1) that were
induced or repressed in the presence of DNp73 similar to the
metastatic phenotypes, which are characterized by enhanced
apoptosis resistance (Soengas et al., 2001; Alla et al., 2010).
Consistent with changes in cell migration and invasiveness, aOctober 14, 2013 ª2013 Elsevier Inc. 515
Figure 3. DNp73 Causes Deregulation of Tumor Progression-Related Genes
(A) Gene expression profiles from melanoma cell lines. The Venn diagram (left) displays that 1,041 (blue) from 1,376 DNp73 regulated genes (gray circle) are
differentially expressed in metastatic SK-Mel-103 or SK-Mel-147 cells (5,987, white circle). Green, black, and red shading of the heat map indicates low,
(legend continued on next page)
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Initiation of Invasion-Metastasis Cascade by DNp73large number of tumor progression-related genes indicated a
marked reduction or increase in SK-Mel-29.DNp73 compared
to mock cells (CHL1, SEMA6A, CEACAM1, LIMA1, CD44,
COL4A1, COL4A2, RHOB, ITGB5, and EPHA2). An additional
set of genes regulated by DNp73 falls into the category of
EMT. All genes related to tumor progression were also found
differentially down- or upregulated in microarray screens of
both metastatic lines compared with SK-Mel-29. To validate
this approach, we further measured the expression levels of
selected genes with qPCR (Figure 3C).
Next, we examined whether ectopic DNp73 can promote
molecular alterations of EMT (Huber et al., 2005). According to
SK-Mel-29.DNp73 cells, we observed a loss of E-cadherin and
increased levels of Slug, fibronectin, vimentin, and N-cadherin
in MDCK and SK-Mel-28 (Figures 3D and 3E).
EPLIN is a Key Target of p73 and DNp73 in Invasion
To detect relevant direct targets of antagonistic p73, we
compared our microarray data with the ChIP-Seq results from
a TP73 gene signature-based approach (Rosenbluth et al.,
2008) using the GeneVenn (http://genevenn.sourceforge.net/)
online Tool. Analysis showed that 200 (108 up and 92 down) of
1,376 genes differentially expressed between mock and SK-
Mel-29.DNp73 cells are potentially regulated by p73 (Figure 4A).
Due to the inhibitory function of DNp73, downregulated targets
whose expression could reduce malignant progression were of
particular interest. Among those, we found the gene encoding
the actin-binding protein EPLIN. Supporting our qPCR data in
Figure 3C, EPLIN is expressed at a substantially lower amount
in SK-Mel-29.DNp73 than in mock cells (Figure 4B, top). A clear
inhibitory effect on both EPLIN isoforms was also seen after
ectopic expression of DNp73 in SK-Mel-29 cells (center). As
demonstrated in Figure 4B (bottom), both EPLINa and EPLINb
proteins increased after specific knockdown of DNp73 in these
cells. Lower EPLIN levels were found in all highly metastatic mel-
anoma cell lines with a slight variation in the affected isoform
(Figure 4C). While EPLINb is always absent, the level of EPLINa
varies.
Then we determined whether the potential p73 binding site in
the intronic region of the human LIMA1 locus (Rosenbluth et al.,
2008) is transcriptionally regulated by the transcription factor
(Figure 4D). Reporter assays using a fragment within the first
intron ranging from position 43,729 to 43,233 upstream of
the EPLINa transcriptional start site in SK-Mel-103 (Figure 4E,
upper) and p53-negative H1299 cells (Figure S2A) showed a
strong (11- to 28-fold) induction of luciferase activity when
cotransfected with wild-type p73 isoforms. Empty vector or
DNp73 alone had no effect in SK-Mel-103 cells with per se
endogenously low EPLIN levels (whereas in SK-Mel-29 cells
with high EPLIN levels shown in Figure S2B, DNp73 significantlyintermediate, or high expression (center). Functional annotation clustering of gene
named by the gene ontology term of the group member with the most significan
(B) Gene expression levels for a subset of genes that aremelanoma related, cell de
green, low expression.
(C) QRT-PCR of selected tumor progression-related genes in SK-Mel-29.DNp73 c
represent mean values of three separate samples measured in triplicate ± SD.
(D and E) Expression of EMT markers in response to DNp73 analyzed by immun
loading. DAPI was used for nuclear staining. Scale bar, 20 mm.
Cblocked reporter activity). Cotransfection of p53 itself in H1299
cells caused only minor reporter activity (Figure S2A). Of note,
p73-dependent luciferase activity was completely inhibited by
coexpression of increasing concentrations of DNp73. This p73-
dependent stimulation or DNp73-dependent inhibition of the
reporter construct was also seen in other metastatic cell lines
such as SK-Mel-147 and C8161 (data not shown). In addition
to the overexpression experiments, we assessed the regulation
of the LIMA1-intronic fragment under physiological levels of
DNp73 and p73 in SK-Mel-103 and A375M (Figure 4E, lower).
After depletion of DNp73 by ASO116, these cells can be induced
to upregulate reporter activity via the LIMA1-intronic fragment
compared to the control. We also tested the EPLINa and EPLINb
promoter sequences containing putative p53 binding sites for
p73/p53 responsiveness but did not observe any significant
effect (data not shown). ChIP assays in SK-Mel-29 cells demon-
strated that direct binding of wild-type p73 and the truncated
isoform occurs via this intronic element (Figure 4F) but not via
the p53 binding sites in the EPLINa and EPLINb promoter (data
not shown). These data indicate that the LIMA1 locus contains
a functional p73 responsive element that leads to the upregula-
tion of both EPLIN isoforms as shown after transduction of
different metastatic cell lines with Ad.p73 (Figure 4G). In turn,
exposure of SK-Mel-29 mock cell to infection with Ad.DNp73
abolished protein expression (Figure 4B, center), fortifying that
LIMA1 is transcriptionally downregulated through DNp73 by
interfering with wild-type p73 tumor suppressor function.
To clarify if DNp73 induces cell migration and invasiveness via
repression of EPLIN, we transfected SK-Mel-29 with isoform-
specific shRNA against EPLINa/b (sh941) and analyzed changes
in invasion. Considering that EPLINb is lost in invasivemelanoma
cell lines (Figure 4C), we intended to elicit the contribution of this
isoform by designing sh817 specific for b. The knockdown effi-
ciency of sh817 and sh941 on both isoforms is shown in Fig-
ure 5A, left. Inhibition of EPLIN reverted the lower migratory
behavior of mock cells to that seen in DNp73-expressing cells
(Figure 5A), whereas upregulation of EPLIN in SK-Mel-
29.DNp73 or C8161 by Ad.p73 reduced the number of invading
cells (Figure 5B). A significant increase in invasion was also
evident upon EPLINb and EPLINa/b depletion in SK-Mel-94
and Mel888 cells (Figure 5A). Consistently, there was a profound
diminishment in invasion of aggressively growing SK-Mel-
29.DNp73 (Figure 5C), SK-Mel-103 (Figure 5D) as well as
A375M and WM793 cells (Figure S3A) following overexpression
of EPLINa and EPLINb. From these results, we can conclude that
both EPLIN isoforms have an inhibitory effect on invasion. In
accordance with the role of both EPLIN isoforms in preventing
invasion, knockdown of these leads to similar physical changes
in the actin cytoskeleton compared to those observed under
high DNp73 levels (Figure 1E; Figure S3B).s regulated by DNp73 in SK-Mel-29 is shown on the right. Enriched groups are
t p value and are ranked by the groups enrichment score.
ath genes, or related tomigration and invasion, and EMT. Red, high expression;
ells. Fold expression was calculated after normalization with B2M. Bar graphs
oblot (D) and immunofluorescence (E). Blots were probed with actin for equal
ancer Cell 24, 512–527, October 14, 2013 ª2013 Elsevier Inc. 517
Figure 4. Specific Function of Individual p73 Family Members in EPLIN Regulation
(A) Venn chart displays the intersection of 1376 DNp73 regulated genes in SK-Mel-29 and 2253 potential direct p73 targets identified by ChIP-Seq (Rosenbluth
et al., 2008). From 200 potentially DNp73 regulated genes, 108 are upregulated and 92 are downregulated. LIMA1 encoding EPLIN belongs to the group of
downregulated genes.
(legend continued on next page)
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Initiation of Invasion-Metastasis Cascade by DNp73Expression of DNp73 and EPLIN in Human Cancer
Tissues
Based on the above findings, we compared the levels of
DNp73 and EPLIN expression in vivo at the stages of mela-
noma progression where an EMT-like switch may take place
(namely at the invasive front of primary melanomas, when
they colonize the underlying dermis) before metastasizing to
different organs using human samples of different Breslow
depth (depth of invasion of melanoma; Figure 5E, left) and in
primary tumors versus metastases from patients with mela-
noma (Figure 5E, right). Because no isoform-specific antibody
is available for immunohistochemical detection of endogenous
DNp73 protein, qPCR is the method of choice for quantifica-
tion of DExon2/3p73 in tumor tissues. As demonstrated in Fig-
ure 5E (left), DNp73 levels positively correlate with Breslow
depth of the primary melanomas (>4 mm, high DNp73 ex-
pression versus <1 mm, low DNp73 expression; p < 0.001).
Conversely, EPLIN expression (both EPLINa and EPLINb
isoforms) and Breslow depth show an inverse correlation
with low EPLINa/b levels at >4 mm depth of invasion versus
high EPLINa/b levels at <1 mm (p = 0.031). Moreover, we
observed a statistically significant higher level of DNp73
transcript in combination with a loss of EPLIN expression in
melanoma metastases compared to the primary group (Fig-
ure 5E, right). In addition to the data obtained for both EPLINa
and EPLINb (Figure 5E), this inverse expression was also
found for EPLINb alone (Figure S3C). In all of the clinical mel-
anoma specimens analyzed here, metastasis also correlated
with p73 expression (data not shown). Increased TP73 levels
and loss of LIMA1 expression are also clearly associated
with the metastatic behavior and tumor grading of other
aggressive cancer types as determined by bioinformatic anal-
ysis of two published microarray studies (Chandran et al.,
2007; Rickman et al., 2008) and one data set made available
to the Oncomine Database by the International Genomics
Consortium under the Expression Project for Oncology
(expO; Figure 5F). Although selective DNp73 expression data
are not available from these studies, statistically significant
associations were found between high DNp73 levels and
poor prognosis parameters such as lymph node metastasis
and vascular invasion in advanced colorectal, breast, and
lung cancer cases based on immunohistochemical analyses
(Domı´nguez et al., 2006).(B) Immunofluorescence staining (red) and immunoblots for endogenous EPLIN e
Nuclei were stained with PI. Scale bar, 20 mm.
(C) Expression of endogenous EPLINa and -b in less and highly invasive melano
(D) Human LIMA1 genomic structure with transcription start sites of EPLINa and E
promoter. A potential p73 binding motif within the first intron 43 kb upstream of
(E) Upper: SK-Mel-103 was cotransfected with 0.5 mg of pGL3_LIMA1-intronic fr
empty vector. The p73 plasmid was cotransfected with increasing amounts of D
A375M cells with high endogenous DNp73 were transfected with 3 mg of pGL3_LI
scrambled control. Luciferase activities (RLU) are shown 24 hr after transfection r
concentration. Error bars indicate one SD of the mean from three separate expe
See also Figure S2.
(F) ChIP in SK-Mel-29 cells 48 hr after infection with Ad.p73, Ad.DNp73, or Ad.GF
was detected by PCR amplification with specific primers spanning region43,645
promoter were used as positive control. Input represents DNA extracted from c
tification as percentage of input.
(G) EPLIN protein levels in infected metastatic melanoma cell lines. Actin shows
CInhibition of EPLIN through DNp73 Induces STAT3 and
AKT Signaling
Immunoblots indicated that phosphorylation of STAT3 and AKT
was higher in melanoma cells ectopically and stably expressing
DNp73, whereas MAP kinase signaling was not significantly
affected (Figure 6A). Activation of STAT3 in the presence of
DNp73 involves enhanced tyrosine-705 phosphorylation of
STAT3 in the cytoplasmic and nuclear fraction (Figure 6B). As
seen in SK-Mel-29 cells transfected with shEPLIN, knockdown
of EPLIN increased the levels of p-STAT3 and p-AKT with the
strongest activation of STAT3 at Y705 induced through
shEPLIN(817) directed against the b-isoform (Figure 6C). More-
over, we detected a clear correlation between elevated EPLIN
protein and diminished p-STAT3 and p-AKT levels in stable
SK-Mel-29.DNp73 cells, after transient p73 expression (Fig-
ure 6D). Accordingly, inhibition of DNp73 in these cells, which
opposes EPLIN blockade, goes along with lower levels of acti-
vated STAT3 and AKT (data not shown). Likewise, substantial
reduction of STAT3 and AKT phosphorylation was induced
through selective DNp73 knockdown in different metastatic
melanoma cells (Figure 6E).
Considering our observation that overexpression of DNp73
leads to increased Slug and reduced levels of E-cadherin (Fig-
ures 3E and 3F), we further investigated DNp73-mediated
changes on signal transduction in the context of these EMTmol-
ecules. We found that DNp73-induced STAT3 activation has no
significant influence on Slug and E-cadherin levels in AG490
treated SK-Mel-29.DNp73. While activated AKT is not affected
by AG490 in DNp73-expressing cells, reduced levels of p-AKT
after treatment with AKT-specific inhibitor VIII correlate with
decreased Slug and increased E-cadherin protein levels (Fig-
ure 6F). With respect to the reduction of invasive growth
observed in melanoma cell lines with high DNp73 after overex-
pression of EPLINa and EPLINb (shown in Figures 5C and 5D),
we also examined the effect of EPLIN on STAT3 or AKT phos-
phorylation and both EMT markers in these cells. As shown for
stable SK-Mel-29.DNp73, enforced expression of EPLIN yields
a substantial decrease in p-STAT3 and p-AKT compared to con-
trol cells, which is associated with downregulation of Slug and
upregulation of E-cadherin (Figure 6G). This suggests that
changes in cell adhesion and migration by DNp73 are mediated
via activation of AKT and STAT3 signaling in response to EPLIN
inhibition.xpression in different melanoma cell lines. Individual treatments are indicated.
ma cell lines. Actin was used for equal loading.
PLINb, positions of exon E1-E11, and putative p53 binding sites in the a and b
the EPLINa promoter is marked in red.
agment (43,729 to 43,233) and 0.5 mg of indicated expression plasmids or
Np73 expression vector (0.5 mg, 1.5 mg, and 2.5 mg). Lower: SK-Mel-103 and
MA1-intronic fragment and 250 nM of the antisense oligonucleotide ASO116 or
elative to pcDNA or scrambled control set as 1 and normalized to total protein
riments.
P using p73(ER15) antibody or IgG control. Binding to the intronic p73 element
to43,392 from the EPLINa transcriptional start site. Primers for theCDKN1A
hromatin prior to immunoprecipitation. Bar graphs show densitometric quan-
equal loading.
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Figure 5. EPLIN Is Implicated in DNp73-Induced Invasiveness
The effect of selective lentiviral knockdown of EPLINb (sh817) or EPLINa/b (sh941), ectopic p73 expression by Ad.p73, and lentivirus-mediated overexpression of
EPLINa or EPLINb on melanoma cell invasion was analyzed by Boyden chamber assay. Cells with scrambled shRNA (shscr) (A) and transduced with Ad.GFP
(legend continued on next page)
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Initiation of Invasion-Metastasis Cascade by DNp73EMT-like Phenotypic Switch Induced by theDNp73-p73-
EPLIN Axis Involves IGF1R Activation
To obtain mechanistic insights into how EPLIN regulates AKT
and STAT3 activities, we examined the activation pattern of re-
ceptor tyrosine kinases in stable DNp73 and parental melanoma
cells using Human Phospho-RTK Antibody Proteome Profiler
Array (R&D Systems). Relative levels of tyrosine phosphorylation
of RTKs among these cell lines were determined as a ratio rela-
tive to positive control’s intensity in each membrane. We found
that the insulin-like growth factor 1 receptor (IGF1R) was highly
activated in SK-Mel-29.DNp73. Decreased expression of EPLIN
in response to DNp73 was associated with increased levels of
phosphorylated and to a lesser extent total IGF1R protein (Fig-
ure 7A, left). This was also evident from immunofluorescence
staining of IGF1R and EPLIN, indicating high p-IGF1R and low
EPLIN protein levels at the cell membrane of DNp73 cells (Fig-
ure 7A, right). IGF1R phosphorylation was clearly abolished by
overexpression of p73 as well as DNp73 knockdown (Figure 7B),
suggesting that receptor activation occurs through the DNp73/
p73-dependent regulation of EPLIN. Indeed, enhanced phos-
pho-IGF1R levels were also detectable after knockdown of
EPLIN in SK-Mel-29 cells and this effect involves significant
changes in E-cadherin and Slug expression relevant for EMT
(Figure 7C). Loss of E-cadherin expression, which was induced
by EPLIN depletion, is well recognized as causing disruption of
cell-cell contacts and release of invasive tumor cells from pri-
mary tumors (Hazan et al., 2004). Interestingly, we observed a
clear increase of phospho-IGF1R after selective inhibition of
E-cadherin by shCDH1 that was accompanied by high levels of
phosphorylated AKT and STAT3 (Figure 7D), thereby consti-
tuting a causal link between the DNp73-EPLIN axis, IGF1 recep-
tor-AKT/STAT3 activation, and EMT. The importance of these
connections was confirmed by the finding that DNp73-induced
AKT/STAT3 phosphorylation and reduced E-cadherin levels
(Slug protein high) were not ascertained in the presence of the
p-IGF1R inhibitor II, a cell-permeable phenylquinolinyl-urea
compound that inhibits IGF1R autophosphorylation (Figure 7E).
In addition, we demonstrated that activated IGF1R contrib-
utes to DNp73 driven EMT-like phenotypic conversion and
invasion. Boyden chamber assays revealed a significantly
impaired capacity of melanoma cells ectopically and endoge-
nously overexpressing DNp73 to invade upon blockade of
IGF1R signaling, whereas motility of mock cells remained unaf-
fected (Figure 7F), allowing the conclusion that endogenous
DNp73 promotes cancer progression via EPLIN-IGF1R path-
ways. Consistent with these data, we detected a clear correla-(B) or empty control virus (C and D) were normalized to 1. Values of invasion are
DNp73 was verified by western blot using actin as control (A, left, C, and D). Val
See also Figure S3.
(E) Quantification of DNp73 and both EPLINa and -b isoforms in human melanom
invasion) <1 mm (n = 8) versus >4 mm (n = 8). Each symbol represents one tum
metastatic melanomas (n = 30). Box plots show relative mRNA expression after
rounding the median. The lines represent the minimum and maximum transcript
Tumors of Breslow depth > 4 mm and metastases showed high DNp73 and low
Student’s t test (two tailed).
(F) Association of LIMA1 and TP73 mRNA levels with the metastatic potential or
solid lines within the boxes represent the median value and boxes show the 25th t
intervals, with circles representing outliers. Statistical significance was calculate
See also Figure S3.
Ction between elevated DNp73 expression, low levels of EPLIN
and E-cadherin, and high levels of phospho-IGF1R, phospho-
AKT, and phospho-STAT3 in invasive tumor xenografts and
metastases from the animal studies described in Figure 2
(Figure 7G).
Selective knockout of Slug delivered a first hint for the direct
effect on E-cadherin, namely its repression. As seen in Fig-
ure 7H, depletion of Slug does not significantly influence the
activation of the IGF1R-AKT/STAT3 pathway, but induces the
release of E-cadherin repression. This argues for an order of
events that places E-cadherin downstream of this signaling
cascade. Kinetic analysis performed on a nonmetastatic cell
line after DNp73 overexpression sets receptor activation into a
perspective with EMT-related events. While the influence of
DNp73 on EPLIN correlates in time with the activation of
p-IGF1R, p-AKT, and p-STAT3 (increase at 12 hr), the upregula-
tion of Slug and E-cadherin reduction, however, trails all other
changes (Figure 7I).
The exclusive position of DNp73 at the switch toward metas-
tasis initiation is finally underlined by the fact that neither muta-
tions in the oncogenes BRAF and NRAS (VanBrocklin et al.,
2009) nor alterations in the other p73 family proteins p53 (Soen-
gas et al., 2001) and p63 (Figure S4A) contribute to the results
described here (Figure S4C). Moreover, we can exclude that
p73 and p63 cooperate in the transcriptional regulation of
LIMA1/EPLIN (Figure S4B, left and middle) and migration/
invasion of melanoma cells (Figure S4B, right).
DISCUSSION
Despite ongoing research toward more specific drugs, metas-
tasis remains an insuperable burden. Here, we provide evidence
that DNp73 initiates the invasion-metastasis cascade in human
malignant melanoma cells. DNp73 expression in tumor cell
lines that are defined as nonmetastatic increased their invasive
growth, whereas selective knockdown of high endogenous
DNp73 protein levels in cells with high metastatic potential
reversed this capability. DNp73-dependent morphological
changes toward an aggressive phenotype were characterized
by the reorganization of actin stress fibers with a loss of the
melanocyte lineage-specific differentiation regulator MITF. This
is consistent with recent data that identified MITF as a critical
marker of proliferative melanoma cells, which is absent from
the invasive state (Hoek et al., 2008). Mouse xenograft experi-
ments revealed that orthotopic tumors of originally nonmeta-
static skin cancer cells expressing DNp73 invade surroundingshown as relative fold change, *p < 0.01. Expression of EPLINa, EPLINb, and
ues are means ± SD.
a samples by qRT-PCR. Left: primary melanomas of Breslow depth (depth of
or. The horizontal line represents the median. Right: primary (n = 20) versus
normalization to 18S rRNA. The box indicates the 25% and 75% quartile sur-
levels. Relative expression was calculated using the comparative Ct method.
EPLIN levels compared to controls. Statistical significance was determined by
tumor grade of prostate, colon, and head and neck cancer. In each graph, the
o 75th percentile range of EPLIN mRNA levels. Bars represent 95% confidence
d by the Mann-Whitney U-test.
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Figure 6. Mutual Regulation of EPLIN
through Antagonistic p73 Proteins
Accounts for Changes in STAT3 and AKT
Signaling
(A) Immunoblot of total and phosphorylated
STAT3, AKT, MEK, and ERK1/2 in SK-Mel-
29.DNp73 and after DNp73 overexpression in
SK-Mel-28 compared to controls. DNp73 and
actin levels are as indicated.
(B) Subcellular localization of p-STAT3(Y705) in
the nuclear and cytosolic fraction of SK-Mel-29
with and without DNp73. Actin and TBPwere used
for equal loading.
(C–E) Levels of p-STAT3 and p-AKT after knock-
down of EPLINb (sh817) and EPLINa/b (sh941) in
SK-Mel-29 (C), infection of SK-Mel-29.DNp73with
Ad.p73b (D), and ASO116 treatment of SK-Mel-
103 or A375M cells (E).
(F) Protein levels of E-cadherin, Slug, total and
phosphorylated STAT3 or AKT in SK-Mel-29 and
SK-Mel-29.DNp73 cells 48 hr after treatment with
AG490 (left) and AKT Inhibitor VIII (right). DMSO
treated cells were used as control.
(G) Immunoblot for E-cadherin, Slug, p-
STAT3(Y705), and p-AKT(S473) in response to
lentiviral overexpression of EPLIN in SK-Mel-
29.DNp73.
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Initiation of Invasion-Metastasis Cascade by DNp73tissues and form metastases. Strikingly, tumor growth itself is
not influenced, which is in contrast to the finding that DNp73
enhances proliferation in normal cells (Stiewe et al., 2003;
Tannapfel et al., 2008) and shows that this protein exhibits an
independent ability in neoplastic cells by acting exclusively
prometastatically.
A prerequisite for increased cell motility and evasion from the
primary tumor is that individual cells break down cell-cell
contacts and remodel cell-matrix adhesion sites (Yilmaz and
Christofori, 2009). Our findings demonstrate that expression of
DNp73 is sufficient for this EMT-like phenotypic switch. We
show that DNp73 directly interferes with wild-type p73-depen-522 Cancer Cell 24, 512–527, October 14, 2013 ª2013 Elsevier Inc.dent transactivation of the LIMA1-intronic
fragment, resulting in EPLIN downregula-
tion. Most importantly, this DNp73 activ-
ity is reflected by an inverse correlation
between high DNp73 and low EPLIN
expression in melanoma metastases.
EPLIN exists as two isoforms, EPLINa
and EPLINb, which differ by 160 amino
acids and arise due to the transcription
initiation from two distinct promoter sites
(Chen et al., 2000). These isoforms
appear to exert similar functions based
on the presence of critical domains
involved in actin binding and a central
LIM domain in each protein (Abe and
Takeichi, 2008). Our data indicate that
both EPLINa and -b isoforms are sup-
pressed by DNp73 and that this corre-
lates with the cells’ invasive andmetasta-
tic potential. A previous report inverselycorrelated EPLINa expression with the aggressiveness and clin-
ical outcome of breast cancer (Jiang et al., 2008). Moreover,
EPLINa overexpression in prostate cancer cells was shown to in-
fluence aggressive traits, such as cell invasiveness and the abil-
ity to adhere to extracellular matrix (Sanders et al., 2011). Our
study reveals that apart from the relative abundance of EPLINa
in highly malignant melanoma cell lines, EPLINb is downregu-
lated in all cases. However, because knockdown of EPLINb by
sh817 or overexpression of the b isoform also has a mild effect
on EPLINa expression, pointing toward amutual influence of iso-
form expression, our results support that inhibition of both EPLIN
isoforms promote the invasive phenotype of melanoma cells.
Cancer Cell
Initiation of Invasion-Metastasis Cascade by DNp73Taking into account that the EPLIN isoform expression varies be-
tween different melanoma cell lines, it is likely that total EPLIN
protein determines the invasiveness of a tumor cell. EPLIN is
located along actin stress fibers and focal adhesion plaques,
suggesting a potential role in maintaining cell morphology and
adhesion. In fact, recent reports have shown that expression of
EMT markers such as E-cadherin are inhibited after EPLIN
depletion (Zhang et al., 2011) by an as yet unknown mechanism.
Several lines of evidence emphasize that constitutive activa-
tion of AKT and STAT3 affects cancer metastasis including met-
astatic melanoma (Govindarajan et al., 2007; Davies et al., 2009;
Xie et al., 2006; Huang, 2007). We found that increased phos-
phorylation of AKT and STAT3 in melanoma cells through
DNp73 involves EPLIN downregulation that can be reversed by
wild-type p73, suggesting that both p73 and DNp73 differentially
control conversion of cancer cells into an invasive and metasta-
tic state by regulating the EPLIN-STAT3/AKT axis. This raised
the question of how EPLIN influences AKT and STAT3 activities
in our cancer model. Phospho-receptor tyrosine kinase
screening revealed the transmembrane type 1 insulin-like growth
factor receptor as mediator by which DNp73 stimulates AKT/
STAT3 pathways. IGF1R, which is commonly upregulated during
melanoma progression (All-Ericsson et al., 2002), signals down-
stream via AKT and STAT3 (Zong et al., 2000; Chapuis et al.,
2010) and receptor activation or overexpression is associated
with increased propensity for invasion and metastasis. Our find-
ings clearly demonstrate that the effect of DNp73 on AKT/STAT3
phosphorylation and subsequent melanoma cell invasion is
abrogated by chemical inhibition of IGF1R activation. Similarly,
knockdown of either EPLIN or E-cadherin reinforced receptor
phosphorylation, providing evidence for a crosstalk between
EPLIN and IGF1R signaling. The significance of this link is high-
lighted by the observation that EPLIN depletion leads to the loss
of E-cadherin, and E-cadherin-mediated adhesion can inhibit
ligand-dependent IGF1R activation (Qian et al., 2004). This
strongly supports that DNp73 contributes to an EMT-like pheno-
type and invasion via the EPLIN-IGF1R axis, suggesting a model
(Figure 8) in which inhibition of EPLIN expression by DNp73 may
cause disintegration of adherens junctions and remodelling of
the actin cytoskeleton associated with the disruption of cell-
cell contacts (Huber et al., 2001). These changes are likely to
liberate IGF1R for ligand-dependent stimulation and augment
AKT and STAT3 activation. Moreover, our study clearly shows
that increased AKT phosphorylation in the presence of DNp73
corresponds with reduced E-cadherin levels. This is in accor-
dance to previous data indicating that expression of a constitu-
tively active form of AKT mimics IGF induction by driving an EMT
(Grille et al., 2003). In addition to internalization of E-cadherin,
activated AKT has been reported to block CDH1 gene transcrip-
tion via accumulation of Slug, which represses the CDH1 pro-
moter (Malmlo¨f et al., 2008; Wang et al., 2009). This was also
observed in our model where specific inhibition of p-AKT in mel-
anoma cells with high DNp73 results in the downregulation of
Slug and upregulation of E-cadherin, thereby underlining the
function of Slug in repressing E-cadherin. Depletion of Slug,
however, which leads to the upregulation of E-cadherin, to be
precise, loss of E-cadherin reduction has no effect on IGF1R-
AKT/STAT3 activity, indicating that reduced E-cadherin expres-
sion per se is not a precondition for the activation of IGF1R-AKT/CSTAT3 signaling. In other words, DNp73-mediated downregula-
tion of EPLIN may be sufficient to alter this pathway in the
presence of initially stable E-cadherin protein levels. From these
data, we can further conclude that EPLIN regulates E-cadherin
expression only after IGF1R-AKT/STAT3 has been stimulated.
That E-cadherin reduction indeed occurs downstream of the
IGF1R-AKT/STAT3 signaling cascade was finally confirmed by
kinetic analysis of these proteins in less invasive cells.
The function of DNp73 in promoting cancer aggressiveness
provides an intriguing explanation for the poorly understood
metastasis and worse survival of patients with cancer with aber-
rantDNp73expression. Inmelanomametastasesandsomeother
highlymetastatic humancancers,N-terminally truncatedp73 is in
most cases expressed in the absence of p53 mutations. The
transdominant activity of DNp73 is thus a suitable mechanism
bywhich this oncogene acts equivalently tomutated p53 for con-
verting tumor cells with intact p53 and/or p73 into an invasive and
metastatic form.On theother hand, our experimentspoint toward
an additional activity of DNp73,which delineates its function from
the recently identified invasive potential of mutant p53 (Muller
et al., 2009) and DNp63g (Lindsay et al., 2011). In contrast to
the integrin recycling-based mechanism of mutant p53, which is
independent of the loss of wild-type p53 function, DNp73 targets
adherens junctions that facilitate cell-cell adhesion. Although in
some tumors DNp73 is indeed expressed at higher levels than
full-length p73, resulting in an increased DNp73/p73 ratio, p73
is coexpressed with DNp73 in most cancers and also in mela-
noma metastases and patient-derived tumor cell lines (Tuve
et al., 2004; present data). This fits in with the proposed model
because EPLIN expression is low in highly invasive/metastatic
cells andmetastases even in thepresenceof highp73 levels, sug-
gesting that the inhibitory effect of DNp73 prevails over p73 acti-
vation. In fact, our data show that DNp73 is essential for tumor
progression even under equally elevated p73 and DNp73
mRNA levels (likely due to the higher stability of DNp73 protein)
because its selective knockdown in metastatic tumor cells
strongly reduces invasion.Consistentwith the view that the capa-
bility of DNp73 to antagonize p73 function is crucial for cancer
progression, the degree of tumor invasion increased with down-
regulation of wild-type p73 expression in other forms of cancer
(Masuda et al., 2003).
In summary, we uncovered the mechanism as to how DNp73
initiates the invasion-metastasis cascade via EPLIN depletion.
Our findings provide conclusive evidence that reduction of EPLIN
has the potential to disrupt cell-cell adhesion via disorganization
of the adherens junctions, which promotes IGF1R signaling.
This is followed by the attenuation of E-cadherin expression
and an EMT-like phenotype. Considering our sparse knowledge
of the key events promoting tumor progression, this function
of DNp73 draws an immediate clinical focus on N-terminally
truncated forms of the p73 family and makes them targets for
drug design against cancer dissemination.EXPERIMENTAL PROCEDURES
Cell Culture and Plasmids
SK-Mel-19, -28, -29, -94, -103, -147, Mel888, A375M, WM793, C8161,
HEK293, HEK293T, H1299, NIH/3T3, and MDCK cells were cultured as
described in the Supplemental Experimental Procedures. For the generationancer Cell 24, 512–527, October 14, 2013 ª2013 Elsevier Inc. 523
Figure 7. EMT-like Switch and Invasion by the DNp73-p73-EPLIN-AKT/STAT3 Pathway Involves Stimulation of IGF1R
(A) Western blots (left) and immunofluorescence (right) of p-IGF1R, IGF1R, and EPLIN expression in SK-Mel-29.DNp73 versus parental cells. Blots were probed
with actin for equal loading. DAPI was used for nuclear staining. Scale bar, 10 mm.
(legend continued on next page)
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Figure 8. Model of p73 and DNp73 Activity in Primary versus Advanced Stage Melanoma
Schematic illustration of DNp73-stimulated melanoma progression, comparing the less (left) versus the more aggressive state (right). DNp73 upregulation during
melanoma development induces the destabilization of cell contacts via repression of LIMA1. Reduction of EPLIN eventually leads to the activation of the IGF1R-
AKT/STAT3 signaling axis followed by an increase of Slug and consecutive attenuation of E-cadherin expression. Loss of contacts between tumor cells thus
enables them to leave the primary site to invade surrounding tissue and metastasize to distant organs.
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Initiation of Invasion-Metastasis Cascade by DNp73of stable cell lines, SK-Mel-29 cells were transfected with empty vector
(pIRESpuro2) or plasmid-expressing DEx2/3bp73. cDNAs encoding EPLINa
or -b and LIMA1 reporter fragments were created with PCR amplification.
Viral Vectors
Lentiviral vectors encoding EPLINa, EPLINb, or shEPLINa/b (941), shEPLINb
(817), shCDH1, and scrambled shRNA (shscr) were generated as described
in the Supplemental Experimental Procedures.
Wound Healing, Matrigel Invasion, Immunoblotting,
Immunofluorescence, Luciferase Reporter Assays, and ChIP
Experiments were performed as described previously (Alla et al., 2010) and in
the Supplemental Experimental Procedures.
Human Malignant Melanoma Tissues
For molecular analysis, ex vivo fresh frozen primary melanoma (n = 20) and
melanoma metastases (n = 30) were investigated by real-time RT-PCR. This(B) Immunoblot showing IGF1R inactivation after adenoviral overexpression of p7
in A375M cells. Ad.GFP was used as control.
(C–E) Detection of phosphorylated IGF1R protein in parental and DNp73-expres
phospho-IGF1R inhibitor II (E). Expression levels of E-cadherin, IGF1R, EPLIN,
appropriate antibodies. Actin was used for equal loading. Scrambled (scr) shRN
(F) Relative invasion of stable DNp73 SK-Mel-29 and A375M cells with endogen
Boyden chamber. Bars represent means of three independent experiments ± SD
(G) Immunohistochemistry of xenograft mouse tumors with high levels of DNp73 (S
were stained with antibodies against EPLIN, E-cadherin, p-IGF1R/p-IGF1R, p-A
(H) Effect of Slug depletion on the expression or activation of indicated proteins
(I) Kinetic analyses of the EPLIN > IGF1R > AKT/STAT3 > Slug/E-cadherin cascad
as control.
See also Figure S4.
Cstudy was approved by the Ethics Committees of the Universities of Rostock
and Kiel, Germany, and informed consent was obtained from all subjects.
Microarrays and qRT-PCR
Total RNA was extracted with NucleoSpin RNA II (Machery-Nagel). The sam-
ples were analyzed for gene expression using Affymetrix GeneChip Human
Genome U133 Plus 2.0 Arrays and further processed with GeneSpring GX
9.0 (Agilent Technologies) as described in the Supplemental Experimental Pro-
cedures. For qRT-PCR, RNA was reverse-transcribed with Omniscript RT
(QIAGEN). cDNA samples were mixed with iQ SYBR Green Supermix and
analyzed on iQ5 Multicolor Real-Time PCR Detection System (Bio-Rad).
Animal Experiments and Immunohistochemistry
Female NMRI nude mice were obtained from Charles River. For analysis of
local tumor growth, 5–10 mice were s.c. injected with 5 3 106 stably trans-
fected vector control SK-Mel-29 or SK-Mel-29.DNp73 cells in the rear flanks.
Tumor volumes were measured twice weekly using calipers. After 4–6 weeks,
Matrigel Matrix HC (Becton Dickinson) was installed as a surrogate for invasive3 in stable DNp73 melanoma cells or ASO116-mediated knockdown of DNp73
sing melanoma cells after treatment with shEPLIN(941) (C), shCDH1 (D), and
Slug, p-AKT, p-STAT3, total AKT and STAT3, and DNp73 were depicted by
A and DMSO served as controls.
ously high DNp73 levels 24 hr after IGF1R-Inhibitor II treatment measured by
. Values of DMSO treated cells were set as 1 (*p < 0.01).
K-Mel-29.DNp73) and without DNp73 (SK-Mel-29) shown in Figure 2. Sections
KT/AKT, or p-STAT3/STAT3. Scale bar, 100 mm.
in SK-Mel-29.DNp73 cells. Actin served as loading control.
e in Ad.DNp73 infected Mel888 cells at 0, 12, 24, 36, and 48 hr. Actin was used
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later, tumor with Matrigel plug was excised and processed for histological ex-
amination. To study spontaneous metastasis, 2 3 106 melanoma cells stably
expressing control or DNp73 were washed in PBS, diluted in Matrigel (1:1),
and 100 ml of the mixture was injected into the mammary fat pad. Tumors
were measured weekly and removed at 1.6 cm diameter. Lungs and liver
were harvested 5 weeks after surgical excision of the primary tumor and
analyzed for metastatic involvement. Tissues were fixed in paraformaldehyde,
paraffin-embedded, and stained with hematoxylin and eosin (H&E). For immu-
nohistochemistry, 4 mm thick slices were cut, pretreated in citrate buffer for
5 min, blocked with horse serum, and then incubated overnight using the
following primary antibodies and dilutions: AKT (clone 11E7, 1:50, Cell
Signaling Technology), phospho-AKT(Ser473) (D9E, XP Rabbit mAb, 1:25,
Cell Signaling Technology), STAT3 (clone 124H6, 1:50, Cell Signaling
Technology), phospho-STAT3 Tyr705 (clone D3A7, 1:100, Cell Signaling
Technology), IGF1R (1:50, Cell Signaling Technology), phospho-IGF1R
Tyr1161 (1:100, Novus), EPLIN (NBP1-87947, 1:100, Novus), and E-cadherin
(clone 24E10, 1:50, Cell Signaling Technology). Slides were washed and
developed using a Universal Elite ABC Kit PK-7200 (Vector Laboratories)
and scanned by a Mirax Midi Slide Scanner (Zeiss Microsystems) at a resolu-
tion of 230 nm. All animal procedures were conducted in adherence to ethical
standards and with approval of the local Animal Care Committee.Statistical Analysis
Statistical significance was calculated by paired Student’s t test. All statistical
tests used in this study were two sided.ACCESSION NUMBERS
The GEO accession number for the raw data from the Oncomine database
reported in this paper is GSE2109. The ArrayExpress accession number for
microarray data generated in this study is E-MEXP-3911.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and Figures S1–S4 and can be found with this article online at http://dx.doi.
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